Knee Injuries

·MeSH: Knee Injuries

Prevalence

28698.8 / 100K

Incidence

12639.0 / 100K/yr

8 drugs in development·5 companies·3 clinical trials

Drug Pipeline by Phase

Phase 4(8)

Drug	Company
Acetaminophen 325Mg Tab	Structure Therapeutics Inc. (GPCR)
Acetaminophen 325Mg Tab	Cidara Therapeutics, Inc. (CDTX)
Acetaminophen 325Mg Tab	Filana Therapeutics Inc. (FLNA)
Norco 5Mg-325Mg Tablet	PROTHENA CORP PUBLIC LTD CO (PRTA)
Norco 5Mg-325Mg Tablet	Cidara Therapeutics, Inc. (CDTX)
Norco 5Mg-325Mg Tablet	Filana Therapeutics Inc. (FLNA)
Norco 5Mg-325Mg Tablet	Structure Therapeutics Inc. (GPCR)
Norco 5Mg-325Mg Tablet	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

BioSniper tracks 8 drugs in development for Knee Injuries across 5 companies.

There are 3 clinical trials targeting Knee Injuries tracked by BioSniper.

The estimated prevalence of Knee Injuries is approximately 28698.8 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.